PCI Biotech (Norway) Technical Analysis
| PCIB Stock | NOK 1.40 0.10 6.67% |
As of the 3rd of December, PCI Biotech holds the market risk adjusted performance of (0.93), and Variance of 48.14. In respect to fundamental indicators, the technical analysis model allows you to check helpful technical drivers of PCI Biotech, as well as the relationship between them. Please check PCI Biotech Holding treynor ratio, value at risk, and the relationship between the information ratio and maximum drawdown to decide if PCI Biotech Holding is priced fairly, providing market reflects its current price of 1.4 per share.
PCI Biotech Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as PCI, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PCIPCI |
PCI Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
PCI Biotech Holding Technical Analysis
The output start index for this execution was twenty-eight with a total number of output elements of thirty-three. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of PCI Biotech Holding volatility. High ATR values indicate high volatility, and low values indicate low volatility.
PCI Biotech Holding Trend Analysis
Use this graph to draw trend lines for PCI Biotech Holding. You can use it to identify possible trend reversals for PCI Biotech as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual PCI Biotech price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.PCI Biotech Best Fit Change Line
The following chart estimates an ordinary least squares regression model for PCI Biotech Holding applied against its price change over selected period. The best fit line has a slop of 0.0078 , which may suggest that PCI Biotech Holding market price will keep on failing further. It has 122 observation points and a regression sum of squares at 2.3, which is the sum of squared deviations for the predicted PCI Biotech price change compared to its average price change.About PCI Biotech Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of PCI Biotech Holding on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of PCI Biotech Holding based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on PCI Biotech Holding price pattern first instead of the macroeconomic environment surrounding PCI Biotech Holding. By analyzing PCI Biotech's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of PCI Biotech's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to PCI Biotech specific price patterns or momentum indicators. Please read more on our technical analysis page.
PCI Biotech December 3, 2024 Technical Indicators
Most technical analysis of PCI help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for PCI from various momentum indicators to cycle indicators. When you analyze PCI charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.03) | |||
| Market Risk Adjusted Performance | (0.93) | |||
| Mean Deviation | 3.93 | |||
| Coefficient Of Variation | (2,136) | |||
| Standard Deviation | 6.94 | |||
| Variance | 48.14 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.38) | |||
| Total Risk Alpha | (1.37) | |||
| Treynor Ratio | (0.94) | |||
| Maximum Drawdown | 55.52 | |||
| Value At Risk | (8.54) | |||
| Potential Upside | 5.69 | |||
| Skewness | 3.93 | |||
| Kurtosis | 25.27 |
Other Information on Investing in PCI Stock
PCI Biotech financial ratios help investors to determine whether PCI Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in PCI with respect to the benefits of owning PCI Biotech security.